Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lead Real Estate (LRE) Cash & Equivalents (2022 - 2025)

Lead Real Estate has reported Cash & Equivalents over the past 4 years, most recently at $18.4 million for Q2 2025.

  • For Q2 2025, Cash & Equivalents rose 263.49% year-over-year to $18.4 million; the TTM value through Jun 2025 reached $18.4 million, up 263.49%, while the annual FY2025 figure was $18.4 million, 263.49% up from the prior year.
  • Cash & Equivalents for Q2 2025 was $18.4 million at Lead Real Estate, up from $2.3 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $18.4 million in Q2 2025 and troughed at $2.3 million in Q4 2024.
  • A 4-year average of $5.5 million and a median of $3.1 million in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: tumbled 45.6% in 2024 and later soared 263.49% in 2025.
  • Year by year, Cash & Equivalents stood at $2.9 million in 2022, then surged by 46.74% to $4.2 million in 2023, then tumbled by 45.6% to $2.3 million in 2024, then soared by 706.19% to $18.4 million in 2025.
  • Business Quant data shows Cash & Equivalents for LRE at $18.4 million in Q2 2025, $2.3 million in Q4 2024, and $5.1 million in Q2 2024.